Takao YOSHIDA

Person

Osaka, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Combination comprising EP4 antagonist and immune checkpoint inhibitor
- Patent number 11,065,226
- Issue date Jul 20, 2021
- Ono Pharmaceutical Co., Ltd.
- Takao Yoshida
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substance specific to human PD-1
- Patent number 9,783,609
- Issue date Oct 10, 2017
- Ono Pharmaceutical Co., Ltd.
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substance specific to human PD-1
- Patent number 8,951,518
- Issue date Feb 10, 2015
- Ono Pharmaceutical Co., Ltd.
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of an efficacy marker for optimizing therapeutic efficacy of an...
- Patent number 8,460,886
- Issue date Jun 11, 2013
- Ono Pharmaceutical Co., Ltd.
- Shiro Shibayama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substance specific to human PD-1
- Patent number 8,246,955
- Issue date Aug 21, 2012
- Ono Pharmaceutical Co., Ltd.
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substance specific to human PD-1
- Patent number 7,998,479
- Issue date Aug 16, 2011
- Ono Pharmaceutical Co., Ltd.
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substance that specifically recognizes PD-1
- Patent number 7,858,746
- Issue date Dec 28, 2010
- Ono Pharmaceutical Co., Ltd.
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substance specific to human PD-1
- Patent number 7,563,869
- Issue date Jul 21, 2009
- Ono Pharmaceutical Co., Ltd.
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Biomarkers for determining the effectiveness of immune checkpoint i...
- Publication number 20210198361
- Publication date Jul 1, 2021
- ONO PHARMACEUTICAL CO., LTD.
- Hiroyoshi NISHIKAWA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION COMPRISING EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR
- Publication number 20190255013
- Publication date Aug 22, 2019
- ONO PHARMACEUTICAL CO., LTD.
- Takao YOSHIDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTANCE SPECIFIC TO HUMAN PD-1
- Publication number 20150118234
- Publication date Apr 30, 2015
- Tasuku HONJO
- Tasuku HONJO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTANCE SPECIFIC TO HUMAN PD-1
- Publication number 20130164294
- Publication date Jun 27, 2013
- ONO PHARMACEUTICAL CO., LTD.
- Tasuku HONJO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTANCE SPECIFIC TO HUMAN PD-1
- Publication number 20110280878
- Publication date Nov 17, 2011
- ONO PHARMACEUTICAL CO., LTD.
- Tasuku HONJO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN EFFICACY MARKER FOR OPTIMIZING THERAPEUTIC EFFICACY OF AN...
- Publication number 20110123550
- Publication date May 26, 2011
- ONO PHARMACEUTICAL CO., LTD.
- Shiro Shibayama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substance Specific to Human PD-1
- Publication number 20090263865
- Publication date Oct 22, 2009
- Tasuku HONJO
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substance that Specifically Recognizes PD-1
- Publication number 20090076250
- Publication date Mar 19, 2009
- ONO PHARMACEUTICAL CO., LTD.
- Tasuku HONJO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substance Specific to Human Pd-1
- Publication number 20080025979
- Publication date Jan 31, 2008
- Tasuku Honjo
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substance specific to pd-1
- Publication number 20040241745
- Publication date Dec 2, 2004
- Tasuku Honjo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Takao YOSHIDA

Person

Patents Grantslast 30 patents

Combination comprising EP4 antagonist and immune checkpoint inhibitor

Substance specific to human PD-1

Substance specific to human PD-1

Use of an efficacy marker for optimizing therapeutic efficacy of an...

Substance specific to human PD-1

Substance specific to human PD-1

Substance that specifically recognizes PD-1

Substance specific to human PD-1

Patents Applicationslast 30 patents

Biomarkers for determining the effectiveness of immune checkpoint i...

COMBINATION COMPRISING EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR

SUBSTANCE SPECIFIC TO HUMAN PD-1

SUBSTANCE SPECIFIC TO HUMAN PD-1

SUBSTANCE SPECIFIC TO HUMAN PD-1

USE OF AN EFFICACY MARKER FOR OPTIMIZING THERAPEUTIC EFFICACY OF AN...

Substance Specific to Human PD-1

Substance that Specifically Recognizes PD-1

Substance Specific to Human Pd-1

Substance specific to pd-1